Literature DB >> 10473227

Inhibition of potassium transport and growth of mycobacteria exposed to clofazimine and B669 is associated with a calcium-independent increase in microbial phospholipase A2 activity.

H C Steel1, N M Matlola, R Anderson.   

Abstract

Altered phospholipase A2 (PLA2) activity and its relationship to cation (K+, Ca2+) uptake and growth were investigated in mycobacteria exposed to the riminophenazine antimicrobial agents, clofazimine and B669 (0.15-2.5 mg/L). Microbial PLA2 activity was measured using a radiometric thin-layer chromatography procedure, whereas K+ and Ca2+ transport were measured using 86Rb+ or 42K+ and 45Ca2+, respectively. Short-term exposure (15-30 min) of Mycobacterium aurum A+ or the virulent and avirulent isolates of Mycobacterium tuberculosis H37R to the riminophenazines resulted in dose-related enhancement of microbial PLA2 activity, which was associated with inhibition of K+ influx and growth. Uptake of Ca2+ by mycobacteria was unaffected, or minimally affected, by the riminophenazines at concentrations of < or = 0.6 mg/L, whereas higher concentrations resulted in increased uptake of the cation in the setting of decreased microbial ATP concentrations. The results of kinetic studies using a fixed concentration (2.5 mg/L) of B669 demonstrated that riminophenazine-mediated enhancement of PLA2 activity and inhibition of K+ uptake in mycobacteria are rapid and probably related events that precede, by several minutes, any detectable effects on microbial ATP concentrations and uptake of Ca2+. Inclusion of the extracellular and intracellular Ca2+-chelating agents EGTA (0.2-7.2 g/L) and BAPTA/FURA-2 (0.2-9.5 mg/L), individually or in combination, did not prevent the effects of B669 on mycobacterial PLA2 activity or K+ transport, whereas alpha-tocopherol, which neutralizes PLA2 primary hydrolysis products, antagonized the inhibitory effects of the riminophenazines on microbial K+ uptake and growth. These results demonstrate that the antimycobacterial activities of clofazimine and B669 are related to a Ca2+-independent increase in mycobacterial PLA2, leading to interference with microbial K+ transport.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473227     DOI: 10.1093/jac/44.2.209

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Formation of iodinin by a strain of Acidithiobacillus ferrooxidans grown on elemental sulfur.

Authors:  P Cesková; Z Zák; D B Johnson; O Janiczek; M Mandl
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

2.  Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury.

Authors:  Thomas M Reeves; Patricia A Trimmer; Beverly S Colley; Linda L Phillips
Journal:  Exp Neurol       Date:  2016-06-11       Impact factor: 5.330

3.  Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.

Authors:  Joseph S Cavanaugh; Ruwen Jou; Mei-Hua Wu; Tracy Dalton; Ekaterina Kurbatova; Julia Ershova; J Peter Cegielski
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

Review 4.  Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections.

Authors:  Julian G Hurdle; Alex J O'Neill; Ian Chopra; Richard E Lee
Journal:  Nat Rev Microbiol       Date:  2011-01       Impact factor: 60.633

5.  Functionalized Dioxonaphthoimidazoliums: A Redox Cycling Chemotype with Potent Bactericidal Activities against Mycobacterium tuberculosis.

Authors:  Kevin T Fridianto; Ming Li; Kiel Hards; Dereje A Negatu; Gregory M Cook; Thomas Dick; Yulin Lam; Mei-Lin Go
Journal:  J Med Chem       Date:  2021-10-27       Impact factor: 7.446

6.  Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.

Authors:  Ming Zhang; Claudia Sala; Ruben C Hartkoorn; Neeraj Dhar; Alfonso Mendoza-Losana; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

7.  The membrane as a target for controlling hypervirulent Clostridium difficile infections.

Authors:  Xiaoqian Wu; Philip T Cherian; Richard E Lee; Julian G Hurdle
Journal:  J Antimicrob Chemother       Date:  2012-12-21       Impact factor: 5.790

8.  Purification and characterization of mycobacterial phospholipase A: an activity associated with mycobacterial cutinase.

Authors:  Sarah K Parker; Kathryn M Curtin; Michael L Vasil
Journal:  J Bacteriol       Date:  2007-04-06       Impact factor: 3.490

9.  Expression of the Genes Encoding the Trk and Kdp Potassium Transport Systems of Mycobacterium tuberculosis during Growth In Vitro.

Authors:  Moloko C Cholo; Elizabeth J van Rensburg; Ayman G Osman; Ronald Anderson
Journal:  Biomed Res Int       Date:  2015-08-17       Impact factor: 3.411

10.  Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.

Authors:  Divakar Sharma; Yogesh K Dhuriya; Nirmala Deo; Deepa Bisht
Journal:  Front Microbiol       Date:  2017-12-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.